Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sascha Fauser

Showing results (51-60 of 237) with videos related to

Pageof 24
Sort By:
The British Journal of Ophthalmology|March 13, 2012
Clinical outcome of the artificial iris diaphragm in silicone oil surgeryManuel M Hermann, Philipp S Muether, Leonie Kuhn, et al.
American Journal of Ophthalmology|August 14, 2013
Long-term stability of vascular endothelial growth factor suppression time under ranibizumab treatment in age-related macular degenerationPhilipp S Muether, Manuel M Hermann, Katharina Dröge, et al.
Acta Ophthalmologica|January 25, 2012
Prevalence of age-related macular degeneration in persons aged 90 years and older in CologneManuel Hermann, Albert Caramoy, Sabine Schröder, et al.
Ophthalmology|August 28, 2012
Vascular endothelial growth factor in patients with exudative age-related macular degeneration treated with ranibizumabPhilipp S Muether, Manuel M Hermann, Ulrike Viebahn, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 2, 2017
Comparing Analytic Hierarchy Process and Discrete-Choice Experiment to Elicit Patient Preferences for Treatment Characteristics in Age-Related Macular DegenerationMarion Danner, Vera Vennedey, Mickaël Hiligsmann, et al.
The Patient|June 4, 2016
How Well Can Analytic Hierarchy Process be Used to Elicit Individual Preferences? Insights from a Survey in Patients Suffering from Age-Related Macular DegenerationMarion Danner, Vera Vennedey, Mickaël Hiligsmann, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 11, 2012
Long-term effects of ranibizumab treatment delay in neovascular age-related macular degenerationPhilipp S Muether, Robert Hoerster, Manuel M Hermann, et al.
Retina (Philadelphia, Pa.)|November 15, 2017
COMPARISON OF RESOLUTION OF VITREOMACULAR TRACTION AFTER OCRIPLASMIN TREATMENT OR VITRECTOMYPaula Scholz, Vasilena Sitnilska, Jelka Hess, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 25, 2002
Leber's hereditary optic neuropathy: clinical and molecular genetic results in a patient with a point mutation at np T11253C (isoleucine to threonine) in the ND4 gene and spontaneous recoveryBeate Leo-Kottler, Janina Luberichs, Dorothea Besch, et al.
Investigative Ophthalmology & Visual Science|May 5, 2011
Development of emulsification-resistant silicone oils: can we go beyond 2000 mPas silicone oil?Albert Caramoy, Nadine Hagedorn, Sascha Fauser, et al.
Pageof 24

Showing results (51-60 of 237) with videos related to

Sort By:
Pageof 24
The British Journal of Ophthalmology|March 13, 2012
Clinical outcome of the artificial iris diaphragm in silicone oil surgeryManuel M Hermann, Philipp S Muether, Leonie Kuhn, et al.
American Journal of Ophthalmology|August 14, 2013
Long-term stability of vascular endothelial growth factor suppression time under ranibizumab treatment in age-related macular degenerationPhilipp S Muether, Manuel M Hermann, Katharina Dröge, et al.
Acta Ophthalmologica|January 25, 2012
Prevalence of age-related macular degeneration in persons aged 90 years and older in CologneManuel Hermann, Albert Caramoy, Sabine Schröder, et al.
Ophthalmology|August 28, 2012
Vascular endothelial growth factor in patients with exudative age-related macular degeneration treated with ranibizumabPhilipp S Muether, Manuel M Hermann, Ulrike Viebahn, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 2, 2017
Comparing Analytic Hierarchy Process and Discrete-Choice Experiment to Elicit Patient Preferences for Treatment Characteristics in Age-Related Macular DegenerationMarion Danner, Vera Vennedey, Mickaël Hiligsmann, et al.
The Patient|June 4, 2016
How Well Can Analytic Hierarchy Process be Used to Elicit Individual Preferences? Insights from a Survey in Patients Suffering from Age-Related Macular DegenerationMarion Danner, Vera Vennedey, Mickaël Hiligsmann, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 11, 2012
Long-term effects of ranibizumab treatment delay in neovascular age-related macular degenerationPhilipp S Muether, Robert Hoerster, Manuel M Hermann, et al.
Retina (Philadelphia, Pa.)|November 15, 2017
COMPARISON OF RESOLUTION OF VITREOMACULAR TRACTION AFTER OCRIPLASMIN TREATMENT OR VITRECTOMYPaula Scholz, Vasilena Sitnilska, Jelka Hess, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 25, 2002
Leber's hereditary optic neuropathy: clinical and molecular genetic results in a patient with a point mutation at np T11253C (isoleucine to threonine) in the ND4 gene and spontaneous recoveryBeate Leo-Kottler, Janina Luberichs, Dorothea Besch, et al.
Investigative Ophthalmology & Visual Science|May 5, 2011
Development of emulsification-resistant silicone oils: can we go beyond 2000 mPas silicone oil?Albert Caramoy, Nadine Hagedorn, Sascha Fauser, et al.
Pageof 24